10.1071/RD12091 107 Scherz-ShouvalR.ElazarROSZ
Currently, certain peptides are on an FDA list of substances with "significant safety concerns." And it's risky to purchase peptides that are marketed as supplements
We work closely with each patient to support steady progress, address concerns, and adjust care as needed throughout the journey. Allana Bush, FNP-C, RN, PHN, MSN Medical Weight Loss & Bioidentical Hormone Replacement Therapy Specialist Lake Forest, IL
adults currently use GLP-1 for weight loss Obesity rate: Declined from 39.9 percent (2022) to 36.4 percent (2026) based on self-reported BMI Diabetes diagnosis rate: Stable since 2023 after 15 years of gradual rise Important limitation: Self-reported data
The heart rate increase observed with Retatrutide requires careful cardiovascular monitoring, particularly in patients with pre-existing heart conditions